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A B S T R A C T
Diabesity is an abnormal metabolic condition shown by patients with obesity that develop type 2 diabetes
mellitus. Patients with diabesity present with insulin resistance, reduced vascular response to insulin, and
vascular endothelial dysfunction. Along with the several well-described mechanisms of insulin resistance, a state
of endoplasmic reticulum (ER) stress, where the primary human targets are the adipose tissue, liver, skeletal
muscle, and the foetoplacental vasculature, is apparent. ER stress characterises by the activation of the unfolded
protein response via three canonical ER stress sensors, i.e., the protein kinase RNA-like endoplasmic reticulum
kinase (PERK), inositol-requiring enzyme 1α (IRE1α), and activating transcription factor 6. Slightly diﬀerent cell
signalling mechanisms preferentially enable in diabesity in the ER stress-associated insulin resistance for adipose
tissue (IRE1α/X-box binding protein 1 mRNA splicing/c-jun N-terminal kinase 1 activation), skeletal muscle
(tribbles-like protein 3 (TRB3)/proinﬂammatory cytokines activation), and liver (PERK/activating transcription
factor 4/TRB3 activation). There is no information in human subjects with diabesity in the foetoplacental
vasculature. However, the available literature shows that pregnant women with pre-pregnancy obesity or
overweight that develop gestational diabetes mellitus (GDM) and their newborn show insulin resistance. ER
stress is recently reported to be triggered in endothelial cells from the human umbilical vein from mothers with
pre-pregnancy obesity. However, whether a diﬀerent metabolic alteration to obesity in pregnancy or GDM is
present in women with pre-pregnancy obesity that develop GDM, is unknown. In this review, we summarised the
ﬁndings on diabesity-associated mechanisms of insulin resistance with emphasis in the primary targets adipose,
skeletal muscle, liver, and foetoplacental tissues. We also give evidence on the possibility of a new GDM-asso-
ciated metabolic condition triggered in pregnancy by maternal obesity, i.e. gestational diabesity, leading to ER
stress-associated insulin resistance in the human foetoplacental vasculature.
1. Introduction
Insulin is a hormone that is synthesised and released by the pan-
creatic β-cells in response to a variety of stimuli (Fu et al., 2013). The
cells respond to insulin following activation of insulin receptors ex-
pressed at the plasma cell membrane, which leads to modiﬁcations of
intracellular cell signalling ending in activation of cell metabolism.
When a defective insulin signalling is seen, cells are metabolically
disturbed and the normal physiological response to this hormone is
altered, including disruption of the classical phosphatidylinositol 3 ki-
nase (PI3K)-protein kinase B/Akt (Akt) and mitogen-activated protein
kinases (MAPK) signalling pathways (Villalobos-Labra et al., 2017).
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Reduced insulin signalling is referred as insulin resistance, a condition
seen in subjects aﬀected with metabolic diseases such as obesity or type
2 diabetes mellitus (T2DM).
Obesity is a metabolic disease whose prevalence is increasing
worldwide (WHO, 2018). Obese subjects show a high risk of developing
hypertension, coronary heart disease, cardiovascular disease, T2DM,
and insulin resistance. Also, maternal obesity in pregnancy results in
diﬀerent alterations in the normal physiology of the placenta leading to
altered foetal development and growth (Desoye, 2018; Van De Maele
et al., 2018). Thus, obesity is a disease with deleterious consequences
from the gestational life through the whole lifespan period. Obesity-
associated organs and cells dysfunction results from a condition where
the endoplasmic reticulum (ER) homeostasis is disrupted. These al-
terations lead to a state of ER stress which characterises by an increase
in the unfolded protein response (UPR) in most cells, including adipo-
cytes and vascular endothelium (Van De Maele et al., 2018; Villalobos-
Labra et al., 2017, 2018).
A large fraction of obese patients results in developing T2DM and
are considered a group of subjects with an unhealthy condition referred
to as ‘diabesity’ (Kalra, 2013; Ziv and Shaﬁr, 1995). Patients with T2DM
account for 90–95% of all diabetes and show a progressive loss of β-cell
insulin secretion with abnormal insulin sensitivity due to defective cell
signalling after activation of insulin receptors in the target tissues (ADA,
2018). Subjects at higher risk of developing this disease show previous
maternal history of diabetes or gestational diabetes mellitus (GDM)
during their gestational period, family history of T2DM, belong to
certain racial/ethnic subgroup such as Native American, African
American, Latino, and Asian American, or show signs of insulin re-
sistance or conditions associated such as hypertension, dyslipidaemia,
polycystic ovary syndrome, or being small-for-gestational age at birth.
Obesity management is the main line of action aiming to reduce the
prevalence or incidence of T2DM (ADA, 2018). Therefore, a direct re-
lationship concerning metabolic alterations between these two diseases
is seen. One of these common links between T2DM and obesity is ER
stress (Van De Maele et al., 2018) (Fig. 1). Patients with T2DM show
with inﬂammation, a common condition between patients with obesity
and T2DM (Esser et al., 2014), where a multi-organ dysfunction is seen
including the liver, skeletal muscle, adipose tissue, brain, pancreas, and
placenta. ER stress in T2DM also results in glucotoxicity, lipids asso-
ciated toxicity, or apoptosis in an organ or cell-speciﬁc manner.
ER stress being an alteration in the function of organs and cells in
the human body in obesity or T2DM, results in a potential target for
treating or even preventing these disease-associated alterations in in-
sulin resistance in diﬀerent insulin target organs. However, it is unclear
whether patients with diabesity (i.e., obese patients that develop
T2DM) (Kalra, 2013; Ziv and Shaﬁr, 1995) show abnormal tissue and
ER homeostasis. In this review, the potential role of ER stress in insulin
resistance and the involvement of these alterations in the abnormal
organ and cell function seen in diabesity is summarised.
2. Diabesity
Diabesity is the term used to deﬁne the result of a combination of
several factors determining metabolic disorders with a state of insulin
resistance (Kalra, 2013; Potenza et al., 2017; Ziv and Shaﬁr, 1995). It
was originally described that patients that were obese and as a con-
sequence of this metabolic pathology develop T2DM are considered as
aﬀected by diabesity (Kalra, 2013; Ziv and Shaﬁr, 1995). It is unclear
whether patients that are overweight and develop T2DM must be
considered as patients aﬀected by diabesity or a diﬀerent clinical ﬁgure.
The increased incidence of T2DM and obesity worldwide shows a pat-
tern of metabolic alterations that are not exclusive for obesity or T2DM,
but a mix of clinical parameters, thus making every time more diﬃcult
to separate patients with obesity from those with T2DM only. Patients
showing diabesity present with common characteristics that have been
described for obesity or T2DM including endothelial and vascular, as
well as skeletal muscle, adipose tissue, and liver dysfunction in response
to vasoactive endogenous molecules such as insulin, adenosine, or en-
dothelin-1 (Campia et al., 2014; Pardo et al., 2017; Silva et al., 2017).
3. Endoplasmic reticulum stress
The homeostasis of the endoplasmic reticulum (ER), an organelle in
charge of the synthesis and processing for secretory and membrane
proteins, Ca2+ storage, and lipid biosynthesis (Cnop et al., 2012;
Flamment et al., 2012), is maintained by a variety of modulatory me-
chanisms securing cell survival, proliferation, growth, among others. A
disturbance of this state results in an altered metabolism and ER stress
(Ghemrawi et al., 2018; Hetz et al., 2015; Mukherjee et al., 2015) as
reported in patients with obesity, T2DM, GDM, or diabesity (Van De
Maele et al., 2018; Villalobos-Labra et al., 2017, 2018).
ER stress results in accumulation of misfolding proteins and acti-
vation of UPR in most cells (Ghemrawi et al., 2018; Mukherjee et al.,
2015; Van De Maele et al., 2018), including the human adult (Kaplon
et al., 2013) and foetal endothelium (Villalobos-Labra et al., 2018). The
UPR activation is intended to restore the defective homeostasis of the
endoplasmic reticulum and characterises by the activation of three
canonical ER stress sensors, i.e., the protein kinase RNA-like en-
doplasmic reticulum kinase (PERK), inositol-requiring enzyme 1α
(IRE1α), and activating transcription factor 6 (ATF6) (Ghemrawi et al.,
2018; Hetz et al., 2015; Mukherjee et al., 2015; Villalobos-Labra et al.,
2018).
PERK phosphorylates the eukaryotic translation initiator factor 2
Fig. 1. Diabesity and endoplasmic reticulum stress. Obesity is a pathology
associated with severe metabolic alterations which, in most cases, end in sub-
jects developing type 2 diabetes mellitus (T2DM). Several speciﬁc mechanisms
are reported to associate with these diseases among which the endoplasmic
reticulum stress (ER stress) is one of these alterations that seems to be a
common factor. ER stress results in abnormal cell signalling in response to in-
sulin leading to systemic insulin resistance in these individuals that are
nowadays referred as aﬀected by diabesity. The metabolic condition of dia-
besity results from the congregate of the cell signalling alterations seen in-
dividually in patients with obesity and T2DM.
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(eIF2), which attenuates the general protein translation but increases
the translation of some proteins (Komar and Hatzoglou, 2011) in-
cluding the activating transcription factor 4 (ATF4), a key transcription
factor for PERK-modulated gene expression. IRE1α shows kinase and
endoribonuclease activity catalysing the processing of X-box binding
protein 1 (XBP1) mRNA, cleaving a 26-nucleotide intron, and shifting
the reading frame to translate the transcription factor XBP1 spliced
(XBP1s). The cytosolic domain of IRE1α binds to tumour necrosis factor
receptor-associated factor 2 (TRAF2), activating the IκB kinase β (IKKβ)
and c-jun N-terminal kinase 1 (JNK1) pathways through IRE1α kinase
domain. ATF6 translocates to the Golgi where it is cleaved. The cleaved-
oﬀ cytoplasmic domain acts as a transcriptional activator for several
genes. Through the expression of chaperones, such as binding im-
munoglobulin protein, calnexin, or calreticulin, foldases (e.g. protein
disulﬁde isomerase A3), and genes involved in redox metabolism, an-
tioxidant proteins, autophagy, and apoptosis (e.g. CCAAT-enhancer-
binding protein homologous protein (CHOP)) among others, UPR is
aimed to reduce the unfolded protein load and to increase the size and
the folding capacity of ER to restore its homeostasis (Cnop et al., 2012;
Dufey et al., 2014; Hetz et al., 2015).
4. Diabesity and ER stress-induced insulin resistance
ER stress is a key phenomenon in the obesity- and T2DM-associated
adverse metabolic outcomes, including insulin resistance in key meta-
bolic organs (Table 1) (Cnop et al., 2012; Flamment et al., 2012). The
causes leading to ER stress are still not well deﬁned; however, one of
the proposed causes is the increase in the circulating proinﬂammatory
cytokines seen in these metabolic conditions (Esser et al., 2014). Cy-
tokines, such as tumour necrosis factor α (TNFα) or interleukin 6 (IL-6)
induce ER stress in diﬀerent cell types (Denis et al., 2010; Hardy et al.,
2012; Hu et al., 2006; McArdle et al., 2013; Xue et al., 2005). Also, the
major concentration of free fatty acids (FFAs) in blood seen in obesity
and T2DM (Boden, 2009; Mandal et al., 2017) contributes to the gen-
eration of ER stress in diﬀerent cell types (Alhusaini et al., 2010; Jiao
et al., 2011; Kim et al., 2015). Hyperglycaemia and hyperinsulinemia,
common characteristics in the metabolic syndrome-associated diseases,
are also shown to induce ER stress in human tissues (Boden et al.,
2014b) (Fig. 2). However, studies in diabesity patients are necessary to
deﬁne clearly the potential factors involved in this particular metabolic
abnormality.
Several mechanisms linking ER stress with insulin resistance
through the direct disruption of the insulin signalling pathway are de-
scribed, but currently, the most supported by literature are two me-
chanisms proposed in the contexts of obesity and T2DM. The ﬁrst one is
an IRE1α-dependent activation of JNK1, which results in insulin re-
ceptor substrate 1 (IRS1) inhibitory serine phosphorylation in obesity
associated-systemic insulin resistance (Flamment et al., 2012; Hirosumi
et al., 2002; Ozcan et al., 2004). The second mechanism involves ac-
tivation of PERK/eIF2/ATF4 signalling leading to increased expression
of tribbles-like protein 3 (TRB3) (Ohoka et al., 2005), a pseudokinase
that inhibits Akt activity promoting insulin resistance (Du et al., 2003;
Flamment et al., 2012; Ozcan et al., 2013). As shown below, JNK1
activation and TRB3 expression are increased in diﬀerent organs from
patients with obesity or T2DM. Thus, JNK1 and TRB3 are suggested as
links involved in diabesity-induced insulin resistance. Here we sum-
marise the available information of the main metabolic organs asso-
ciated to diabesity-associated metabolic alterations.
4.1. Adipose tissue
Adipose tissue is considered a master regulator of systemic energy
homeostasis by being involved in energy expenditure by thermogenesis,
energy storage, and in the regulation of key metabolic organs, such as
liver, skeletal muscle, and pancreas (Kusminski et al., 2016). Adipose
tissue is of two types: brown adipose tissue, involved in thermogenesis,
and white adipose tissue (WAT), as the major adipose depot in the body
contributing to the control of systemic metabolic homeostasis (McArdle
et al., 2013). WAT is sub-grouped depending on its anatomical location,
i.e., the subcutaneous adipose tissue (SAT) and visceral adipose tissue
(VAT). WAT plays a key role in the regulation of insulin sensitivity in
target tissues, such as skeletal muscle and liver, two of the main organs
involved in D-glucose homeostasis control (Bjørndal et al., 2011; Hardy
et al., 2012; Wilcox, 2005). Thus, dysfunction of the adipose tissue is a
condition tightly related to the development of insulin resistance con-
tributing to the development of obesity-associated T2DM or diabesity
(Kohlgruber and Lynch, 2015; Kusminski et al., 2016).
Although the whole WAT is involved in insulin resistance, an in-
crease in only the VAT volume in obesity was associated with higher
risk to develop insulin resistance and T2DM (Bjørndal et al., 2011;
Hardy et al., 2012). The regulation of insulin sensitivity by WAT is
mainly given by its function as an endocrine organ through the release
of adipokines (adipocytes-derived hormones). Leptin and adiponectin
increase but TNFα, IL-6 or interleukin 1 (IL-1) decrease the insulin
sensitivity in targets organs (Hardy et al., 2012; McArdle et al., 2013).
On the other hand, the increase of VAT volume in obesity and the in-
sulin resistance itself result in a higher release of FFAs into the circu-
lation leading to the accumulation of these molecules in target tissues,
including the skeletal muscle and liver. This phenomenon induces
toxicity and promotes insulin resistance in these tissues (Kahn and Flier,
2000; McArdle et al., 2013). Thus, a better understanding of the me-
chanisms that regulate WAT function in diabesity may be relevant in
the control of systemic insulin resistance in patients with this abnormal
metabolic condition.
ER stress is also seen in association with adipose tissue dysfunction.
ER stress is detected in SAT (Alhusaini et al., 2010; Boden et al., 2008;
Díaz-Ruiz et al., 2015; Vendrell et al., 2010) and VAT (Alhusaini et al.,
2010; Liong and Lappas, 2015; Vendrell et al., 2010) from patients that
are overweight or obese (Table 1). Interestingly, loss of weight reduces
ER stress in WAT as seen after bariatric surgery (Gregor et al., 2009).
Thus, WAT from patients with obesity also presents ER stress. On the
other hand, T2DM has also been related with ER stress in the adipose
tissue, particularly in SAT (Boden et al., 2014a) and VAT (Li et al.,
2014). Currently, there are no studies addressing ER stress in subjects
with diabesity; however, some reports refer to patients with T2DM that
were also with overweight or obesity, even when they do not refer to
these subjects as having diabesity (Boden et al., 2014a; Vendrell et al.,
2010). These studies show that diabetes in obese patients does not
change the ER stress seen in VAT and SAT from subjects only with
obesity. In addition to the studies in obese subjects, and again not
speciﬁcally mentioned by the authors, pregnant women aﬀected by
only with obesity and pregnant women with obesity that developed
GDM showed a similar increase of ER stress markers in VAT (Liong and
Lappas, 2015). Thus, GDM does not increase ER stress over that induced
by obesity. These ﬁndings suggest that diabetes per se would not in-
crease the ER stress present in obesity, but diabetes alone also causes ER
stress. Thus, although more studies are still needed in patients with
diabesity, the occurrence of ER stress in adipose tissues from this con-
dition is likely.
ER stress is associated with the development of insulin resistance in
adipose tissue. Induction of ER stress by tunicamycin (ER stress in-
ducer) in human preadipocytes-visceral cells reduced IRS1 and Akt
phosphorylation in response to insulin, which was caused through the
activation of an IRE1α/JNK1 signalling pathway (Li et al., 2014). This
mechanism has been fully described in mice adipocytes and in other cell
types (Ozcan et al., 2004; Xu et al., 2010). IRE1α activation, XBP1
splicing, and JNK1 activation are reported to be increased in adipose
tissue of patients with obesity and in patients with T2DM (Boden et al.,
2008; Li et al., 2014). Despite there are reports on the actual mea-
surement of these proteins in patients with diabesity, the described
ﬁndings strongly suggest that this could be one mechanism of ER stress-
induced insulin resistance in adipose tissue from this type of patients
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(Fig. 2).
TRB3 is another potential link between ER stress and insulin re-
sistance in adipose tissue from diabesity. This protein has been asso-
ciated with the development of insulin resistance in the metabolic
syndrome (Marinho et al., 2015). That relationship is made by a direct
disruption on the insulin signalling pathway through the inhibition of
Akt (Du et al., 2003), a mechanism that is also described in adipocytes
(Du and Ding, 2009). A recent study in rats induced to have diabesity
showed that TRB3 is increased in the adipose tissue and that TRB3 si-
lencing increased insulin response in this tissue and the systemic insulin
sensitivity (Sun et al., 2017). Since TRB3 protein level is reported to be
increased in the blood of patients with obesity (Nourbakhsh et al.,
2017), this protein involvement in adipose tissue insulin resistance is
likely. However, it is still needed to run studies in adipose tissue from
subjects with diabesity.
ER stress in adipocytes not only causes insulin resistance in adipose
tissue, but it is involved in the promotion of insulin desensitisation in
other organs. ER stress associated with reduced adiponectin secretion,
whose plasma level is reduced in patients with obesity and with T2DM
(Blüher, 2014; Yamamoto et al., 2014). Induction of ER stress in human
adipocytes in vitro reduces adiponectin expression (Mondal et al., 2012;
Xu et al., 2010). That is further supported by ﬁndings showing that a
high-fat diet-induced ER stress in VAT and SAT of mice reduced the
release of adiponectin, and that reduction of ER stress increases extra-
cellular adiponectin levels (Torre-Villalvazo et al., 2018). Thus, ER
stress present in the adipose tissue of patients with diabesity could re-
sult in reducing the adiponectin level in the plasma of these subjects.
Studies in vitro and in animal models showed that ER stress pro-
motes the secretion of proinﬂammatory cytokines by the adipocytes
(Kawasaki et al., 2012; Xu et al., 2010). Thus, ER stress may be involved
in the higher secretion of proinﬂammatory cytokines by the adipose
tissue reported in obesity and T2DM, including TNFα, IL-6, and IL-1
(Boden et al., 2014a, 2008; Li et al., 2014). Also, the mentioned cyto-
kines contribute to inducing ER stress and insulin desensitisation in
other organs (Hardy et al., 2012; Kohlgruber and Lynch, 2015; McArdle
et al., 2013). Additionally, insulin desensitisation and ER stress itself
Table 1
Induced endoplasmic reticulum stress in human tissues in pathologies associated with obesity.
Pathology Tissue/cell Eﬀect Protein abundance mRNA level Reference
Diabesitya Skeletal muscle Increase – TRB3 Liu et al. (2010)
Obesity SAT Increase PDI XBP1s Boden et al. (2008)
CRT
CNX P∼ JNK1
Obesity OAT Increase IRE1α XBP1s Liong and Lappas (2015)
BiP
Obesity Adipose tissue Increase P∼ eIF2 XBP1s Sharma et al., 2008
ATF6
Obesity Abdominal SAT Decrease P∼ eIF2 XBP1s Gregor et al. (2009)
BiP
P∼ JNK1
Obesity Abdominal SAT Increase IRE1α ATF6 Alhusaini et al. (2010)
BiP
Obesityb SAT Increase CHOP – Díaz-Ruiz et al. (2015)
P∼ JNK1
Obesity Skeletal muscle Increase IRE1α XBP1s Liong and Lappas (2016)
BiP
Obesity Placenta Increase P∼ eIF2 XBP1s Yung et al. (2016)
Obesity HUVECs Increase P∼ PERK CHOP Villalobos-Labra et al. (2018)
IRE1α TRB3
ATF6c BiP
P∼ eIF2 –
CHOP –
TRB3 –
P∼ JNK1 –
Severe obesityd VAT, SAT Increase BiP XBP1s Vendrell et al. (2010)
T2DM Visceral preadipocytes from OAT Increase P∼ PERK ATF6 Li et al. (2014)
P∼ eIF2 XBP1s
P∼ JNK1 –
P∼ IRE1α –
GDM OAT Increase IRE1α XBP1s Liong and Lappas (2015)
BiP
GDM Skeletal muscle Increase IRE1α XBP1s Liong and Lappas (2016)
BiP
GDM Placenta Increase P∼ eIF2 XBP1s Yung et al. (2016)
GDM HUVECs Increase CHOP – Farías et al. (2010)
Gestational diabesitye OAT Increase IRE1α XBP1s Liong and Lappas (2015)
BiP
Gestational diabesitye Skeletal muscle Increase IRE1α XBP1s Liong and Lappas (2016)
BiP
T2DM, type 2 diabetes mellitus; HUVECs, human umbilical vein endothelial cells; SAT, subcutaneous adipose tissue; OAT, omental adipose tissue; VAT, visceral
adipose tissue; P∼ PERK, phosphorylated protein kinase RNA-like endoplasmic reticulum kinase; TRB3, tribbles-like protein 3; PDI, protein disulﬁde isomerase A3;
CRT, calreticulin; CNX, calnexin; P∼ JNK1, phosphorylated c-jun N-terminal kinase 1 phosphorylated; XBP1s, spliced X-box binding protein 1 mRNA; IRE1α,
inositol-requiring enzyme 1α; BiP, binding immunoglobulin protein; P∼ eIF2, phosphorylated eukaryotic translation initiator factor 2; ATF6, activating tran-
scription factor 6; CHOP, CCAAT-enhancer-binding protein homologous protein. –, not reported.
a Obese subjects with T2DM.
b Comparison between obese subjects with insulin resistance versus obese subjects without insulin resistance.
c Protein translocation to the nucleus.
d Severe obesity refers to BMI≥ 40 kg/m2.
e Pregnancies where the mother was obese and developed gestational diabetes mellitus (GDM).
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result in increased lipolysis and consequent release of FFAs (Deng et al.,
2012; Xu et al., 2010; Zhou et al., 2009), which in turn increase ER
stress and insulin resistance in adipose tissue and other tissues
(Guilherme et al., 2008; Jiao et al., 2011).
4.2. Skeletal muscle
Skeletal muscle is the main site of insulin-mediated D-glucose up-
take in the postprandial state, reaching up to 60–70% of the circulating
D-glucose (Wilcox, 2005). Thus, the metabolic alteration of skeletal
muscle strongly aﬀects the D-glucose homeostasis and the systemic
insulin sensitivity, a phenomenon that plays a key role in metabolic
syndrome-associated diseases (DeFronzo and Tripathy, 2009; Wu and
Ballantyne, 2017). Insulin increases the uptake of D-glucose and pro-
motes its metabolization (glycogen synthesis and glycolysis) in this
organ by activating the Akt-associated metabolic signalling pathway
leading to increased translocation of the D-glucose transporter type 4
from the internal compartments towards the plasma membrane
(Sakamoto and Holman, 2008). In a state of insulin resistance these
mechanisms of signalling are disrupted ending in a reduced capacity of
the skeletal muscle to take up the extracellular D-glucose in response to
insulin and thus contributing to the overdemand at pancreas β-cells, D-
glucose intolerance, and to the development of T2DM (DeFronzo and
Tripathy, 2009). The skeletal muscle from D-glucose tolerant obese
patients (Adams et al., 2004) and patients with T2DM (Reeds et al.,
2006) present insulin resistance in the skeletal muscle tissue. Thus,
insulin resistance in the skeletal muscle tissue in diabesity is highly
probable and could contribute to the systemic insulin resistance.
The development of insulin resistance in skeletal muscle cells in-
volves ER stress (Table 1). An increase of ER stress is reported in ske-
letal muscle from patients with diabesity (these patients were catalo-
gued as having only T2DM in the original report), compared with non-
diabetic lean patients (Koh et al., 2013). Also, pregnant women with
obesity or obesity plus GDM presented signs of ER stress in the skeletal
muscle (Liong and Lappas, 2016). Additionally, higher level of cer-
amide in obese patients have been reported (Adams et al., 2004), a
molecule known to induce ER stress and insulin resistance (Choi et al.,
2018; Flamment et al., 2012; Liu et al., 2014), supporting the existence
Fig. 2. Target organs of endoplasmic reticulum stress in diabesity. Severe metabolic alterations seen in patients aﬀected by obesity and type 2 diabetes mellitus
are referred as a state of diabesity. Patients with diabesity show hyperglycaemia and hyperinsulinemia, as well as higher circulating levels of proinﬂammatory
cytokines and free fatty acids (FFAs). These factors all together induce a state of endoplasmic reticulum stress (ER stress). ER stress is characterised by an increase in
the unfolded-protein response resulting in the activation of canonical ER stress sensors including the protein kinase RNA-like endoplasmic reticulum kinase (PERK)
and the inositol-requiring enzyme 1α (IRE1α). PERK signalling is mediated by the sequential activation by phosphorylation of the eukaryotic translation initiator
factor 2 (P∼ eIF2), transcription factor 4 (ATF4), CCAAT-enhancer-binding protein homologous protein (CHOP), and tribbles-like protein 3 (TRB3) (see text for
details). IRE1α signalling includes the cleavage of the X-box binding protein 1 (XBP1) mRNA to translate the transcription factor XBP1 spliced (XBP1s). Increased
IRE1α signalling also includes activation by phosphorylation of the c-jun N-terminal kinase 1 (P∼ JNK1). The alterations resulting from ER stress result in impaired
insulin signalling ending in increased (⇧) expression and activity of several molecules in the skeletal muscle, adipose tissue, and liver. Instead, adiponectin release
from the adipose tissue instead is reduced (⇩) in this condition. ER stress-impaired insulin signalling leads to reduced insulin-dependent D-glucose uptake in the
skeletal muscle and adipose tissue, and increased gluconeogenesis in the liver. The resulting eﬀect of diabesity on the metabolic modiﬁcations in these organs
specialised in the modulation of the glycaemia includes systemic insulin resistance, hyperglycaemia and hyperinsulinemia.
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of ER stress in this tissue. Other studies show induction of ER stress-
associated impaired insulin signalling in human skeletal muscle cells
(Hage Hassan et al., 2012), the mouse myoblast (C2C12 cells) and rat
skeletal myoblast (L6 cells) cell lines (Hage Hassan et al., 2012; Hwang
et al., 2013; Ijuin et al., 2016; Koh et al., 2013). Similar to what is
described in adipose tissue or liver, TRB3 plays a key role in the im-
paired insulin signalling. An increase of TRB3 protein abundance in
skeletal muscle from obese and diabesity patients (referred by the au-
thors as only showing T2DM) was reported (Koh et al., 2013; Liu et al.,
2010). Overexpression of TRB3 in C2C12 and L6 cells prevented the
insulin-induced D-glucose uptake by inactivation of Akt (Koh et al.,
2013; Liu et al., 2010). Also, the ER stress-induced TRB3 expression
impaired insulin response in mice skeletal muscles, an eﬀect blocked in
C2C12 cells and mice skeletal muscle knockdown for TRB3 (Koh et al.,
2013). Furthermore, TRB3 knocking out prevented the high fat diet
(HFD)-induced insulin resistance in mice skeletal muscle (Koh et al.,
2013). Thus, TRB3 is proposed as a potential protein linking ER stress
with diabesity-induced insulin resistance in the human skeletal muscle.
The involvement of extracellular signal-regulated kinases activation
in the ER stress-induced impairment of insulin signalling pathway,
which ﬁnally resulted in reduced insulin-induced D-glucose uptake by
L6 cells, is reported (Hwang et al., 2013). Moreover, in addition to ER
stress induction, obesity increased the PIP3 phosphatase skeletal muscle
and kidney-enriched inositol polyphosphate 5-phosphatase (SKIP) in
the skeletal muscle from diet induced obesity (DIO) and db/db mice
(Ijuin and Takenawa, 2003). This phosphatase negatively regulates the
insulin signalling pathway, an eﬀect that seems to be mediated by SKIP
expression through ATF6 and XBP1 dependent mechanisms in
C2C12 cells (Ijuin et al., 2016). Altogether, these data show that dia-
besity-induced ER stress could be a key step in the development of in-
sulin resistance in skeletal muscle.
As well as adipose tissue or liver, FFAs are shown to induce ER stress
in the skeletal muscle. This fact takes more importance since skeletal
muscle from obese and diabetic patients has increased ectopic accu-
mulation of FFAs. Palmitate induces ER stress in human skeletal cells
(Hage Hassan et al., 2012; Peter et al., 2009) as well as in human
skeletal muscle, C2C12 myotubes, and L6 cells (Peng et al., 2011; Perry
et al., 2018; Peter et al., 2009; Rieusset et al., 2012; Salvadó et al.,
2013). Palmitate also caused insulin resistance (Hage Hassan et al.,
2012; Peng et al., 2011; Rieusset et al., 2012). However, a reduction of
ER stress by chemical chaperones did not improve the palmitate-in-
duced insulin resistance (Hage Hassan et al., 2012; Rieusset et al.,
2012). Thus, even when palmitate induces ER stress in skeletal muscle
cells, ER stress seems not to be the main mechanism in the palmitate-
induced insulin resistance in skeletal muscle. Also, it is worth noting
that other FFAs, such as oleate, block the palmitate-induced insulin
resistance and ER stress in skeletal muscle cells (Peng et al., 2011;
Salvadó et al., 2013). The latter suggests that a change in fat diet to-
wards a more enriched in unsaturated-FFAs could be beneﬁcial by
improving insulin sensitisation in skeletal muscle from patients with
diabesity.
Skeletal muscle also acts as an endocrine organ regulating the sys-
temic insulin sensitivity through the secretion of hormones known as
myokines, such as musclin, IL-6 or TNFα (Wu and Ballantyne, 2017)
(Fig. 2). These myokines also act in an autocrine or paracrine way and
contribute to insulin desensitisation in most if not all the tissues, in-
cluding the skeletal muscle. It is reported that subjects with obesity or
T2DM present with higher expression of these myokines. The partici-
pation of ER stress in this increase is also possible. Musclin is increased
in obesity and has a strong correlation with insulin resistance (Chen
et al., 2017). This myokine induces the inhibition of insulin-triggered
Akt activation in rat skeletal muscle (Liu et al., 2008) and ER stress in
C2C12 cells (Chen et al., 2017). Additionally, palmitate increases the
expression of musclin in C2C12 cells through the activation of PERK-
associated signalling, suggesting the involvement of ER stress in the
increased secretion of musclin in obesity.
Other studies report that the human skeletal muscle shows in-
creased expression and release of IL-6 in patients with diabesity
(Ciaraldi et al., 2016; Reyna et al., 2008), as well as in insulin-resistant
obese subjects (Corpeleijn et al., 2005; Reyna et al., 2008). Ad-
ditionally, TNFα expression is increased in skeletal muscle from pa-
tients with diabesity (Plomgaard et al., 2007; Saghizadeh et al., 1996),
even more than in patients with only obesity (Plomgaard et al., 2007).
Thus, the skeletal muscle is one of the sources for the increased circu-
lating levels of IL-6 and TNFα seen in diabesity (Goyal et al., 2012).
Since these cytokines also induce ER stress and insulin resistance in
skeletal muscle and other tissues (Borst, 2004; Denis et al., 2010;
Kohlgruber and Lynch, 2015; Liong and Lappas, 2016; Plomgaard et al.,
2005), this could be another way on how the skeletal muscle inﬂuences
or is involved in the development of systemic insulin resistance. The
relation between UPR and diabesity-induced IL-6 or TNFα expression in
skeletal muscle cells is not well understood. It is reported that ER stress
is involved in the expression of cytokines by the human skeletal muscle
(Liong and Lappas, 2016). However, and as described above, ER stress
seems involved in the expression and release of IL-6 and TNFα in other
cell types (Hosoi et al., 2013; Hu et al., 2006; Kim et al., 2015; Li et al.,
2014). Thus, since ER stress is present in the skeletal muscle from
diabesity patients, ER stress could be involved in the increased ex-
pression and release of cytokines seen in this tissue from these subjects.
Altogether the above-mentioned ﬁndings strongly suggest the involve-
ment of ER stress and UPR signalling in the skeletal muscle eﬀect on the
systemic insulin resistance in diabesity by dysregulation of myokines
secretion from this tissue.
4.3. Liver
The liver is a central organ in the control of D-glucose homeostasis
and therefore is key in systemic insulin resistance. Despite that D-glu-
cose uptake is not insulin-dependent in the liver, this organ is re-
sponsible for∼30% of whole body insulin-mediated D-glucose disposal
through insulin-regulated metabolic processes, such as glycogenesis,
inhibition of gluconeogenesis, and release of D-glucose (Wilcox, 2005).
In a state of hepatic insulin resistance all these functions are altered,
resulting in an excessive release of D-glucose by liver, which is con-
sidered as one of the major causes of insulin resistance and hypergly-
caemia in patients with obesity-induced T2DM (Pajvani and Accili,
2015) (Fig. 2). The insulin eﬀect on hepatocytes is mediated by Akt
activation, which leads to inhibition of the expression of gluconeo-
genesis enzymes, among other eﬀects. When hepatic insulin signalling
is impaired, the resulting ineﬃcient gluconeogenesis inhibition leads to
abnormally higher levels of postprandial and fasting glycaemia
(Marinho et al., 2015).
There are no studies addressing ER stress in the liver from subjects
with obesity or diabesity. However, there is strong evidence showing
ER stress in the liver from obese and diabesity mice models (Lisbona
et al., 2009; Ning et al., 2011; Ozcan et al., 2004; Wang et al., 2009).
Considering this latter ﬁnding and since the adipose tissue or skeletal
muscle from subjects with diabesity present with ER stress, it is strongly
suggested that patients with diabesity will show ER stress in the liver.
Interestingly, most of the mechanisms linking obesity-associated ER
stress with insulin resistance have been described in hepatocytes. It is
reported the activation of the three canonical pathways of UPR in mice
liver (Kammoun et al., 2009; Ozcan et al., 2004) an also an association
between ER stress and impaired insulin response in this organ
(Kammoun et al., 2009; Ozcan et al., 2004). Based on results available
in animal models, diﬀerent mechanisms have been proposed to be in-
volved in the UPR-associated insulin resistance in the liver in diabesity
which could be present in humans with this metabolic alteration.
PERK signalling branch has been linked to ER stress-induced insulin
signalling impairment in the liver. It is reported that eIF2 is required for
the gluconeogenesis mechanism by hepatocytes. The liver-speciﬁc
overexpression of a constitutively active form of growth arrest and DNA
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damage-inducible protein GADD34, a speciﬁc phosphatase of eIF2,
prevented the obesity-induced insulin resistance and D-glucose intol-
erance in a model of diet-induced obesity and induced hypoglycaemia
in lean mice (Oyadomari et al., 2008). Moreover, mice expressing an
eIF2 protein unable to be phosphorylated showed severe hypogly-
caemia (Scheuner et al., 2001). Thus, eIF2 seems crucial for gluco-
neogenesis by the liver. The evidence in animal models support ﬁndings
showing a positive correlation between eIF2 phosphorylation and in-
sulin resistance in the liver from obese subjects, suggesting the in-
volvement of PERK branch in liver insulin resistance from these patients
(Kumashiro et al., 2011).
The mechanisms inducing impaired insulin signalling in the liver by
PERK branch involves TRB3. ER stress causes an increase in TRB3
protein level in human hepatocellular carcinoma cells (HepG2) invol-
ving ATF4 and CHOP activity (Ohoka et al., 2005). Genetic mice models
of obesity (ob/ob), diabesity (db/db) (Belke and Severson, 2012), and
DIO showed increased expression of TRB3 in the liver (Du et al., 2003;
Lima et al., 2009). Also, TRB3 knockdown resulted in increased insulin-
induction of Akt activity in HepG2 cells, and TRB3 overexpression re-
duced the insulin-decreased D-glucose release by Fao rat hepatoma cells
(Fao cells). This phenomenon was supported by ﬁndings showing that
speciﬁc overexpression of TRB3 in the liver of mice generated hy-
perglycaemia and an impaired D-glucose tolerance. Besides, in mice
with normal expression of TRB3 in their liver showed increased TRB3
protein levels in the fasting period, potentially contributing to physio-
logical gluconeogenesis by inhibiting the insulin-induced eﬀect on he-
patocytes (Du et al., 2003).
Other studies show that overexpression of TRB3 in the liver induced
systemic D-glucose intolerance and insulin resistance in this organ
(Matsushima et al., 2006). Also, TRB3 coimmunoprecipitate with Akt in
liver from DIO and ob/ob mice, suggesting regulation of Akt by TRB3 in
vivo (Lima et al., 2009). Additionally, it has been shown that calcium/
calmodulin dependent-protein kinase II (CaMKII) is increased in the
liver from obese mice and contributes to insulin signalling impairment
through a mechanism involving PERK/ATF4-mediated TRB3 increase in
primary hepatocytes (Ozcan et al., 2013). Furthermore, potential in-
volvement of TRB3 in the liver from subjects with diabesity is sup-
ported by the ﬁndings showing that this protein expression in patients
with obesity increases in parallel with the development of systemic
insulin resistance (Oberkoﬂer et al., 2010). Altogether these ﬁndings
suggest that PERK activation could be participating in ER stress-induced
hepatic insulin resistance through the expression of TRB3 in diabesity.
IRE1α kinase and endonuclease activity have also been found in-
creased in liver from obese mice (Bailly-Maitre et al., 2010; Ning et al.,
2011; Ozcan et al., 2004). It is shown that activated JNK1 was increased
in liver from ob/ob and DIO mice models. ER stress-induced inactiva-
tion of IRS1 through the IRE1α-induced activation of JNK1 in Fao cells
(Ozcan et al., 2004). Additionally, ER stress induction increased the
expression and activity of the glucose-6 phosphatase, the release of D-
glucose, and blunted the gluconeogenesis inhibition induced by insulin
in primary rat hepatocytes, an eﬀect that was partially mediated by
JNK1 (Wang et al., 2006). Thus, JNK1 is proposed as one of the links in
the ER stress-induced insulin resistance in the liver in obesity. Also,
FFAs, lipopolysaccharides, and other proteins, such as double-stranded
RNA-dependent protein kinase (PKR), have been associated to JNK1
activation and induction of insulin resistance (Flamment et al., 2012).
Thus, ER stress could not be the unique inductor of insulin resistance
through JNK1 activation in the liver.
Other studies show that XBP1 splicing and nuclear localisation is
higher in the liver from DIO mice (Ning et al., 2011). A protective eﬀect
of XBP1 on ER stress-induced insulin resistance in the liver of mice was
seen. Mice with a null mutation in one XBP-1 allele fed with DIO
showed enhanced obesity-induced insulin resistance in the liver and the
systemic insulin resistance and D-glucose intolerance compared with
IRE1α+/+ mice (Ozcan et al., 2004). However, studies modifying XBP1
expression speciﬁcally in the liver showed the opposite results. It was
found that in obese and diabetic mice models (ob/ob, db/db, and DIO),
obesity-induced IRE1α-XBP1 activation was associated with lower ex-
pression of the Bax-inhibitor 1 (BI-1), an ER membrane protein that
inhibits IRE1α endonuclease activity (Lisbona et al., 2009). The re-
storation of liver BI-1 expression by adenovirus in db/db and DIO mice
blunted the obesity-induced IRE1α-XBP1 endonuclease activity, im-
proved insulin response in the liver, and protected from obesity-in-
duced systemic insulin resistance and D-glucose intolerance (Bailly-
Maitre et al., 2010). A conditional hepatic XBP1 depletion in mice
caused lower fructose-induced insulin resistance in the liver and D-
glucose intolerance even when hepatic ER stress and JNK1 activity in
this organ were higher than in wild-type mice (Jurczak et al., 2012).
Thus, JNK1 could not be the unique mechanism involved in the ER
stress-induced insulin resistance in the liver from subjects with dia-
besity. The apparent discrepancy of XBP1 eﬀects on insulin sensitivity
and D-glucose homeostasis could be due to the diﬀerences in the mo-
lecular tools used to evaluate XBP1 involvement. Since XBP1 was
shown to be deleterious for the eﬀect of insulin in animals with genetic
modiﬁcations in their liver, it is likely that hepatic XBP1 may be in-
volved in the ER stress-associated systemic insulin resistance in subjects
with diabesity.
A lower expression of ATF6 is reported in the liver from obese
subjects with insulin resistance compared with non-insulin resistant
subjects (Kumashiro et al., 2011) as well as in db/db mice (Wang et al.,
2009). It is reported that ATF6 acts as a regulator of PERK and IRE1α
resulting in a protective eﬀect against ER stress (Wu et al., 2007).
Overexpression of ATF6, particularly the ATF6α isoform, in the liver of
db/db and DIO mice protected from obesity-induced hyperglycaemia
and expression of various enzymes involved in the liver gluconeogen-
esis process. Conversely, ATF6α knockdown induced hyperglycaemia
and increased the expression of gluconeogenesis enzymes in the liver
from lean mice (Wang et al., 2009). Thus, ATF6 expression and activity
in the liver protects against hyperglycaemia.
It has been reported that improvement of insulin sensitivity in he-
patocytes is also caused by inhibition of CaMKII via a mechanism that
required ATF6 activation (Yan et al., 2002). Activation of ATF6 resulted
in higher expression and activity of p58IPK, which inhibits PERK-
mediated signalling resulting in lower TRB3 expression activation (Yan
et al., 2002) and subsequent increase in the insulin response in hepa-
tocytes (Ozcan et al., 2013). In fact, CaMKII reduces ATF6 expression in
the liver of obese mice, and ATF6 overexpression inhibited PERK/TRB3
branch in the liver, protecting from the obesity-induced insulin re-
sistance in this organ and improving insulin sensitivity and D-glucose
tolerance in DIO mice (Ozcan et al., 2016). Despite there is scarce in-
formation about ATF6 involvement in the liver of patients with dia-
besity or animal models of this metabolic alteration, it is suggested that
ATF6 will play a protecting role in obesity-induced D-glucose metabo-
lism alterations in the liver, a mechanism that could be key in the al-
tered D-glucose metabolism in subjects with diabesity.
Other proteins have also been associated with the ER stress-induced
insulin resistance in the liver. Reduction of ER stress by overexpression
of the endogenous chaperone BiP protected from obesity-induced sys-
temic insulin resistance in ob/ob mice (Kammoun et al., 2009). Also,
the transcription factor Kruppel-like factor 15 (KLF15) is shown to play
a key role in ER stress-induced insulin resistance in the liver. DIO
KLF15−/− mice and DIO mice with liver-speciﬁc KLF15 knockdown
were protected from ER stress-induced liver and systemic insulin re-
sistance. An association was found for an increase in ER stress, cyto-
kines expression, and JNK1 activation, supporting the role of ER stress
in DIO-induced insulin resistance in the mice liver (Jung et al., 2013).
Unfortunately, the mechanisms of KLF15 activity on the insulin sig-
nalling pathway and UPR proteins is still unknown.
4.4. Foetoplacental tissue
Children born to mothers with obesity or GDM are prone to develop
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metabolic disorders in adulthood (Gaillard et al., 2014; Pirkola et al.,
2010; Sobrevia et al., 2014; Stuebe et al., 2012, 2009). Indeed, new-
borns from insulin-resistant obese mothers have already increased in-
sulin resistance at birth (Catalano et al., 2009; Desoye, 2018). Equally,
newborns and the mothers in GDM pregnancies show increased the
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
(Guzmán-Gutiérrez et al., 2016; Subiabre et al., 2017; Westermeier
et al., 2015). Recent reports show that newborns and women with GDM
treated only with diet or under an insulin therapy protocol still show
insulin resistance at birth suggesting that these therapeutic approaches
may resolve the maternal and newborn glycaemia to values within the
required ranges but did not resolve the reduced response of the vas-
culature to insulin (Subiabre et al., 2018, 2017).
Metabolic disorders derived from obesity and GDM may be trans-
ferred from the mother to their oﬀspring (Sobrevia et al., 2014). Several
reports show that this transference occurs during pregnancy (Longtine
and Nelson, 2011; Sobrevia et al., 2014). This possibility is supported
by ﬁndings showing that after the weight loss following a bariatric
surgery, children born from these mothers presented a reduced in-
cidence of obesity and insulin resistance (Guenard et al., 2013; Kral
et al., 2006; Smith et al., 2009) compared to their siblings born before
the intervention. Foetoplacental tissues play a key role in this trans-
ference, since they are the structural and functional connection of the
foetus with the mother (Griﬃths and Campbell, 2015). The placenta is
an organ specialised in vital processes including gas exchange, trans-
port of ions, nutrients and waste products between the maternal and
foetal plasma, and it is active in the synthesis and secretion of hormones
and extracellular vesicles, including nanovesicles (also referred as
exosomes) (Chiarello et al., 2018; Jayabalan et al., 2017; Pardo et al.,
2018; Sáez et al., 2018a), reaching the maternal and foetal circulation
(Chiarello et al., 2018; Sáez et al., 2018a,b). Maternal substances are
transferred from the maternal blood through the chorionic villous into
the foetal capillaries, then blood ﬂows through chorionic veins and
reaches the umbilical vein returning the freshly oxygenated blood to
the foetal circulation (Griﬃths and Campbell, 2015). Even when the
foetoplacental tissues are a transient organ, foetoplacental tissue dys-
function is shown to be crucial in the foetal outcome and altered
function in this tissue remains for the lifetime of the oﬀspring (Longtine
and Nelson, 2011; Sáez et al., 2018a,b; Sobrevia et al., 2014).
Insulin resistance in mothers with obesity is associated with higher
placental weight, an eﬀect not further increased by the co-existence of
GDM (Tanaka et al., 2018). Thus, the mechanisms associated with in-
sulin resistance in pregnant women with obesity and those with GDM
may not be due to similar signalling mechanisms. In a study of the
transcriptome of trophoblast cells from the ﬁrst trimester of pregnancy
in mothers with obesity, the insulin-induced gene expression was found
to be lower compared with cells from normal pregnancies (Lassance
et al., 2015). These ﬁndings suggest lower insulin sensitivity in these
cells from obese mothers. Another set of studies reported that the foe-
toplacental vasculature from mothers with obesity also shows signs of
insulin resistance since an insulin resistance genetic proﬁle in umbilical
cords from obese mothers was found (Thakali et al., 2014).
Vascular insulin resistance is tightly associated with endothelial
dysfunction (Muniyappa and Sowers, 2013; Silva et al., 2017; Sobrevia
et al., 2016; Subiabre et al., 2018; Villalobos-Labra et al., 2017), which
is considered a key step in the beginning of cardiovascular disease
(Versari et al., 2009) and characterises by a lower endothelial-depen-
dent vasodilation (Deanﬁeld et al., 2005; Guzmán-Gutiérrez et al.,
2016; Silva et al., 2017; Sobrevia et al., 2016). Increased resistance of
the umbilical arteries from pregnancies where the mothers were obese
is reported, where the umbilical artery endothelial dysfunction was
suggested as the responsible mechanism of this vascular dysfunction
(Sarno et al., 2015). Furthermore, HUVECs from mothers with pre-
pregnancy maternal obesity (Villalobos-Labra et al., 2018) or mother
with normal weight before pregnancy but with supraphysiological total
gestational weight gain (sptGWG) (Pardo et al., 2015) also presented
metabolic alterations. Altogether these ﬁndings suggest that foetopla-
cental vascular tissues from mothers with obesity or sptGWG are dys-
functional.
Since already three decades the GDM was shown to associate with
alterations in the human placenta and foetoplacental vasculature
(Sobrevia et al., 1994, 1995, 1996). HUVECs from GDM pregnancies
showed a lower response to insulin and other endothelial-dependent
vasodilators (Sáez et al., 2018a; Sobrevia et al., 1996; Subiabre et al.,
2017), a phenomenon proposed to be due to insulin desensitisation and
endothelial dysfunction since L-arginine transport and NO synthesis
were increased compared with normal pregnancies.
Based on the above-described studies it is now clearer that foeto-
placental tissues are altered in pregnancies where the mother was with
obesity, sptGWG, or GDM. However, it is still necessary to reach to a
state where a better-deﬁned selection of pregnant women with pre-
pregnancy obesity or sptGWG developing GDM, i.e., gestational dia-
besity, as recently proposed (Pardo and Sobrevia, 2018), are diﬀerent
from those that do not develop GDM (i.e., true pre-pregnancy obesity or
obesity in pregnancy). These metabolic conditions are diﬀerent for
women with obesity, GDM, or pregnancy diabesity with diﬀerent con-
sequences to the foetus growth and development.
ER stress shows a strong relationship with insulin resistance and
endothelial dysfunction in metabolic syndrome-associated diseases
(Battson et al., 2017; Cnop et al., 2012). It is reported that placentas
from mothers with obesity that develop GDM present higher phos-
phorylation of eIF2 and processed XBP1 levels than control, lean not-
GDM mothers, a ﬁnding that correlates positively with glycated hae-
moglobin A1c level, evidencing a potential inﬂuence of hyperglycaemia
with the induction of ER stress in this tissue (Yung et al., 2016)
(Table 1). Interestingly, the control referred to in the latter study, as
almost in all of the studies with a similar approach and study group
selections, corresponded to women with a normal weight that did not
course with GDM. Thus, a proper comparison to deﬁne the potential
eﬀect of a gestational diabesity state in the reported parameters is
unclear.
Placentas from mothers with obesity or with GDM, showed higher
expression of phosphorylated JNK1 (Saben et al., 2013; Yung et al.,
2016), suggesting this molecule as a potential candidate to obesity-in-
duced, ER stress-associated insulin resistance in foetoplacental tissues
(Fig. 3). Besides, placentas from mothers with GDM (Coughlan et al.,
2004; Desoye and Hauguel-De Mouzon, 2007; Zhu et al., 2015) or
obesity (Bar et al., 2012; Ferretti et al., 2014; Saben et al., 2014) pre-
sented higher levels of inﬂammatory and oxidative markers, which are
tightly associated with ER stress (Flamment et al., 2012). Studies in
HUVECs from GDM pregnancies show higher expression and activity of
CHOP (Farías et al., 2010). The latter phenomenon is related with ab-
normal function of HUVECs since repression of SLC29A1 coding for the
human equilibrative nucleoside transporter 1 (Farías et al., 2010) and
overexpression of SLC7A1 coding for the human cationic amino acid
transporter 1 (Guzmán-Gutiérrez, 2014) associated with increased
CHOP activity. In a recent study, it was reported that HUVECs from
women with pre-pregnancy obesity show activation of PERK, IRE1α,
ATF6, and their downstream proteins, including TRB3 and JNK1
(Villalobos-Labra et al., 2018), suggesting that these cells from this
maternal metabolic condition showed with ER stress. Since maternal
pre-pregnancy obesity associated with higher expression of TRB3 and
activated JNK1, it is suggested that these proteins may play a role
acting as links between obesity-induced ER stress and human foeto-
placental endothelial dysfunction (Villalobos-Labra et al., 2018). Al-
though studies in foetoplacental tissues are still necessary, the reported
ﬁndings suggest ER stress in the human placenta and foetoplacental
vasculature in gestational diabesity.
5. Gender-associated insulin resistance predisposition
Substantial evidence shows that cardiovascular risk tightly
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associated with gender. Interestingly, even when women show higher
adiposity than men, women tend to accumulate fat at subcutaneous
depots, but fat accumulation in men is preferentially at visceral depots
(Geer and Shen, 2009). The gender-dependent fat distribution results in
men showing higher metabolic risk than women. Thus, adolescent
obese males exhibit a higher chance to develop insulin resistance and D-
glucose intolerance (Aldhoon-Hainerová et al., 2014; Denzer et al.,
2009). Also, these subjects show with fatty liver, have a lower level of
plasma adiponectin, and store fat at visceral depots (Denzer et al.,
2009), all factors that contribute to the development of systemic insulin
resistance. Therefore, women show protection against the alterations
mentioned above in the metabolism. One of the causes that are pro-
posed to lead to this protection in women are the sexual hormones.
Oestrogens have been shown to promote insulin sensitivity in metabolic
tissues (Jelenik and Roden, 2013). Interestingly, since oestrogens re-
duced the ER stress in INS-1 cells, a rat insulinoma cell line and human
umbilical vein endothelial cells (Kooptiwut et al., 2014; Su et al., 2017)
a potential mechanism of action of oestrogens could involve protection
against or amelioration of ER stress. However, a protective eﬀect of
oestrogens against the ER stress-associated insulin resistance in women
with diabesity is a mechanism not yet described.
Foetus gender also associated with the metabolic state of the mother
and placental tissues. Pregnant women with male foetuses have higher
HOMA-IR compared with women with female foetuses, evidencing in-
creased risk to develop insulin resistance (Walsh et al., 2015). Indeed,
another study shows that the development of GDM associated with
women carrying a boy compared with those taking a girl (Retnakaran
and Shah, 2015). In addition to these ﬁndings, maternal obesity-in-
duced oxidative stress in the placenta is under modulation by foetal
gender (Evans and Myatt, 2017). The results suggest that the damage in
the placentas from women with obesity where the foetus was male was
higher compared with pregnancies where the foetus was female. Since
oxidative stress associated with ER stress and insulin resistance, obe-
sity-increased oxidative stress in the placenta may result in a higher
occurrence of ER stress in this organ in women with diabesity with a
male foetus which could explain the foetoplacental dysfunction seen in
these women. Altogether, the available evidence, even when limited,
suggests that the sexual dimorphism in fat accumulation, fatty liver,
and systemic insulin resistance could associate with a higher occurrence
of ER stress in men compared with women. Unfortunately, whether ER
stress is also under modulation by gender is still not described
(Sobrevia, 2018; Subiabre et al., 2018; Villalobos-Labra et al., 2017).
6. Concluding remarks
It is now accepted that obesity is pandemic and results in immediate
alterations leading to an abnormal metabolic environment with a dys-
functional vasculature and in abnormal function in diﬀerent targets
including the adipose tissue, liver, and skeletal muscle. Also, pre-
pregnancy maternal obesity and excessive weight gain in pregnancy
result in a dysfunctional foetoplacental vasculature. In most cases,
obese subjects progress to develop T2DM characterised by a defective
uptake and metabolism of D-glucose in most cells as the major factor.
These subjects are more recently referred to as having diabesity high-
lighting the appearance of T2DM in these subjects (Kalra, 2013;
Potenza et al., 2017; Ziv and Shaﬁr, 1995).
Patients with obesity, T2DM, or diabesity show with ER stress, with
pronounced eﬀects in adipose tissue (likely VAT), the liver, skeletal
muscle, and the foetoplacental vascular endothelium. In these tissues
the three canonical branches of ER stress, PERK, IRE1α, and ATF6, are
activated leading to the UPR (Van De Maele et al., 2018), as a me-
chanism intending to restore the altered homeostasis of the en-
doplasmic reticulum seen in these (Ghemrawi et al., 2018; Hetz et al.,
2015; Mukherjee et al., 2015; Villalobos-Labra et al., 2018). ER stress
results in insulin resistance by mechanisms involving IRE1α/JNK1-
mediated inhibition of IRS1-coupled insulin signalling. Alternatively,
activation of PERK/eIF2/ATF4/TRB3 signalling leads to reduced Akt
activity (Du et al., 2003; Flamment et al., 2012; Hirosumi et al., 2002;
Ozcan et al., 2013, 2004) turning in a lower NO, endothelium-depen-
dent vasodilatory eﬀect of insulin (Villalobos-Labra et al., 2018, 2017).
Speciﬁc mechanisms of ER stress-associated insulin resistance in
adipose tissue involve IRE1α activation, XBP1 splicing, and JNK1 ac-
tivation (Boden et al., 2008; Li et al., 2014), as well as lower expression
of the insulin sensitizer adiponectin (Mondal et al., 2012; Xu et al.,
2010) and increased release of proinﬂammatory cytokines TNFα, IL-6,
and IL-1 (Hardy et al., 2012; Kohlgruber and Lynch, 2015; McArdle
et al., 2013). In the skeletal muscle, a role for TRB3 in insulin resistant
is proposed. Additionally, increased release of IL-6 and TNFα in pa-
tients with diabesity (Goyal et al., 2012). The role of ER stress in the
insulin resistance in the human liver is unknown. However, data re-
ported in animal models suggest activation of the three canonical
pathways of UPR, with a major role of PERK/ATF4/TRB3 signalling,
and loss of insulin sensitivity in this organ (Kammoun et al., 2009;
Fig. 3. Endoplasmic reticulum stress in the foetoplacental endothelium in
diabesity. Pregnant women with obesity and type 2 diabetes mellitus classify as
patients with diabesity. This metabolic condition alters the endothelial cells
from the placenta circulation (Placenta vascular endothelium) due to en-
doplasmic reticulum stress (ER stress). ER stress characterises by an increase in
the unfolded-protein response (UPR) leading to activation of the protein kinase
RNA-like endoplasmic reticulum kinase (PERK) and the inositol-requiring en-
zyme 1α (IRE1α), canonical ER stress sensors. PERK triggers the sequential
activation by phosphorylation of the eukaryotic translation initiator factor 2
(P∼ eIF2), transcription factor 4 (ATF4), CCAAT-enhancer-binding protein
homologous protein (CHOP), and tribbles-like protein 3 (TRB3) (see text for
details). On the other hand, IRE1α triggers the activation by phosphorylation of
the c-jun N-terminal kinase 1 (P∼ JNK1). Activation of the PERK and IRE1α
signalling cascades result in a deﬁcient response of the foetoplacental en-
dothelium to insulin (Insulin resistance) due or leading to a dysfunctional
macrovascular (and likely microvascular) endothelium (Foetoplacental en-
dothelial dysfunction). The newborn outcome of the ER stress in the foetopla-
cental vasculature in pregnant women with diabesity is an increase in the risk of
developing cardiovascular diseases (Increased cardiovascular risk in the newborn).
Whether these metabolic alterations are seen in the foetoplacental vasculature
from women with pre-pregnancy obesity or showing supraphysiological total
gestational weight gain that develop gestational diabetes mellitus (i.e. gesta-
tional diabesity) is still unknown.
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Matsushima et al., 2006; Ozcan et al., 2016, 2013, 2004).
In the foetoplacental vasculature the role of ER stress in the insulin
resistant state seen in obesity or GDM has been less studied (Villalobos-
Labra et al., 2017). In fact, most of the studies that refers to GDM show
groups of patients with a body mass index between 25 and 35 kg/m2,
i.e., including women with overweight and obesity (WHO, 2018).
Therefore, not a clear conclusion is possible to reach from such studies
regarding whether the reported eﬀects, including maternal and new-
born insulin resistance, were due to GDM, overweight, obesity, or a mix
of these abnormal metabolic conditions. Whether the occurrence of
GDM in women with pre-pregnancy obesity, which we refer as gesta-
tional diabesity, has a diﬀerent aetiology and result in diﬀerent meta-
bolic consequences for the mother, the foetus, the newborn and their
childhood and adulthood, compared with diabesity as currently known
in the literature (obese patients that develop T2DM), is unknown.
Based on the speciﬁc modiﬁcations in the cell signalling mechan-
isms seen in the general context of ER stress-associated insulin re-
sistance, it is likely that diabesity is an alteration that shows high cell,
tissue, and organ speciﬁcity. The lack of studies in patients that are
overweight and develop T2DM limit the possibility of a potential dif-
ferent or similar type of diabesity as referred up today (Desoye, 2018).
Equally, since obesity in women in their reproductive age is increasing
worldwide in the last decade (WHO, 2018) and GDM is increasing in
parallel to obesity in the population (ADA, 2018), a diﬀerent metabolic
alteration to obesity in pregnancy or GDM, which we refer as gesta-
tional diabesity, is likely. Interestingly, ER stress and insulin resistance
are adverse metabolic conditions in pregnant women that are obese
with stronger harmful eﬀects in the foetoplacental vascular function
whether the foetus was men compared with female. Having a clearer
picture of the mechanisms behind insulin resistance in subjects with
diabesity, overweight + T2DM, or gestational diabesity will help to
understand the clinical aspects of these patients favouring the design of
speciﬁc or at least more diﬀerential protocols for the treatment of each
of these metabolic alterations.
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